Clinical Laserthermia Systems AB (publ)

OM:CLS BTU B Voorraadrapport

Marktkapitalisatie: SEK 81.8m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Beheer

Beheer criteriumcontroles 3/4

Clinical Laserthermia Systems' CEO is Dan Mogren, appointed in Dec 2020, has a tenure of 3.58 years. directly owns 0.075% of the company’s shares, worth SEK61.21K. The average tenure of the management team and the board of directors is 2.5 years and 3.5 years respectively.

Belangrijke informatie

Dan Mogren

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO3.6yrs
Eigendom CEO0.07%
Management gemiddelde ambtstermijn2.5yrs
Gemiddelde ambtstermijn bestuur3.5yrs

Recente managementupdates

Geen updates

Recent updates

Geen updates

Analyse CEO-vergoeding

Hoe is Dan Mogren's beloning veranderd ten opzichte van Clinical Laserthermia Systems's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Mar 31 2024n/an/a

-SEK 71m

Dec 31 2023n/an/a

-SEK 80m

Sep 30 2023n/an/a

-SEK 63m

Jun 30 2023n/an/a

-SEK 77m

Mar 31 2023n/an/a

-SEK 78m

Dec 31 2022SEK 1mSEK 1m

-SEK 71m

Sep 30 2022n/an/a

-SEK 81m

Jun 30 2022n/an/a

-SEK 63m

Mar 31 2022n/an/a

-SEK 68m

Dec 31 2021SEK 2mSEK 1m

-SEK 64m

Compensatie versus markt: Insufficient data to establish whether Dan's total compensation is reasonable compared to companies of similar size in the Swedish market.

Compensatie versus inkomsten: Dan's compensation has been consistent with company performance over the past year.

CEO

Dan Mogren (60 yo)

3.6yrs

Tenure

SEK 1,373,158

Compensatie

Mr. Dan Johansson Mogren was Acting Chief Executive Officer at Clinical Laserthermia Systems AB (publ) since December 01, 2020 until May 2022 and is Chief Executive Officer May 2022 and served as its Chief...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Dan Mogren
Chief Executive Officer3.6yrsSEK 1.37m0.075%
SEK 61.2k
Lars-Erik Eriksson
Co-Founder & Directorno dataSEK 1.65mgeen gegevens
Hakan Rosqvist
Interim Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Jimmy Johansson
Executive Vice President of Operations1.2yrsgeen gegevens0.0014%
SEK 1.1k
Cristina Pantaleone
Chief Technical Officer2.5yrsgeen gegevensgeen gegevens
Liselotte Nilsson
Vice President of Marketing3.5yrsgeen gegevens0.0047%
SEK 3.8k
Karin Peterson
Chief Product Officerno datageen gegevensgeen gegevens

2.5yrs

Gemiddelde duur

57yo

Gemiddelde leeftijd

Ervaren management: CLS BTU B's management team is considered experienced (2.5 years average tenure).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Lars-Erik Eriksson
Co-Founder & Director18.5yrsSEK 1.65mgeen gegevens
Stephan Dymling
Director2.5yrsSEK 75.00k0.0078%
SEK 6.4k
Hans von Celsing
Independent Chairman of the Board11.5yrsSEK 250.00k0.0036%
SEK 2.9k
Gunilla Savring
Independent Director4.5yrsSEK 142.50kgeen gegevens
Rolf Kiessling
Member of Clinical Advisory Board3.1yrsSEK 80.00kgeen gegevens
Karl-Göran Tranberg
Member of Clinical Advisory Board3.1yrsSEK 80.00k0.078%
SEK 63.7k
Paolo Raffaelli
Independent Director3.5yrsSEK 62.50k0.00072%
SEK 588.9
Marika Crohns
Independent Director & Member of Clinical Advisory Board4.5yrsSEK 142.50k0.0070%
SEK 5.7k
Sandy Brandmeier
Independent Director3.5yrsgeen gegevens0.013%
SEK 10.5k

3.5yrs

Gemiddelde duur

69yo

Gemiddelde leeftijd

Ervaren bestuur: CLS BTU B's board of directors are considered experienced (3.5 years average tenure).